The proinflammatory cytokines interleukin 12 (IL-12) and IL-23 connect innate responses and adaptive immune responses and are also involved in autoimmune and inflammatory diseases. Here we describe an epigenetic mechanism for regulation of the genes encoding IL-12 (Il12a and Il12b; collectively called 'Il12' here) and IL-23 (Il23a and Il12b; collectively called 'Il23' here) involving the deubiquitinase Trabid. Deletion of Zranb1 (which encodes Trabid) in dendritic cells inhibited induction of the expression of Il12 and Il23 by Toll-like receptors (TLRs), which impaired the differentiation of inflammatory T cells and protected mice from autoimmune inflammation. Trabid facilitated TLR-induced histone modifications at the promoters of Il12 and Il23, which involved deubiqutination and stabilization of the histone demethylase Jmjd2d. Our findings highlight an epigenetic mechanism for the regulation of Il12 and Il23 and establish Trabid as an innate immunological regulator of inflammatory T cell responses.
Cells of the innate immune system, including dendritic cells (DCs) and macrophages, have an important role in regulating the nature and magnitude of adaptive immune responses 1 . They recognize microbial components via pattern-recognition receptors, including various Tolllike receptors (TLRs), which trigger intracellular signaling events that induce the maturation and function of these cells. DCs function as the main antigen-presenting cells required for activation of naive T cells 2 . In addition, DCs and macrophages produce a plethora of cytokines that regulate the differentiation of CD4 + T cells and promote inflammatory responses 3 . However, deregulated production of proinflammatory cytokines by cells of the innate immune system also contributes to autoimmune and inflammatory diseases. The interleukin 12 (IL-12) family of cytokines, particularly IL-12 and IL-23, are proinflammatory cytokines produced by DCs and macrophages, as well as by fibroblasts in response to microbial infection [4] [5] [6] . IL-12 is composed of the subunits IL-12α and IL-12β and acts as a key mediator in the differentiation of CD4 + T cells toward the type 1 helper T cell (T H 1 cell) lineage, characterized by production of the signature cytokine interferon-γ (IFN-γ) 7 . IL-23, composed of IL-12β and the specific subunit IL-23α, functions to amplify and maintain the T H 17 subset of CD4 + helper T cells 6, 7 . The genes encoding IL-12 (Il12a and Il12b; collectively called 'Il12' here) and IL-23 (Il23a and Il12b; collectively called 'Il23' here) are induced in response to stimulation by various TLR ligands, and IL-12 and IL-23 have been linked to autoimmune and inflammatory diseases 6 . However, the mechanisms that regulate the induction of Il12 and Il23 are incompletely understood.
The transcriptional regulator c-Rel, of the NF-κB family of transcription factors, mediates TLR-stimulated expression of Il12 and Il23 (refs. 8,9) . In addition to activating NF-κB and other transcription factors, TLR signals induce chromatin remodeling at the Il12b promoter, which might be important for accessibility of the promoter region to specific transcription factors 10, 11 . As seen with Il12b, chromatin remodeling allows accessibility of the Il12a promoter to specific transcription factors, such as c-Rel and C/EBP 12 . Similarly, stimulation via TLRs results in histone modifications of the nucleosome located at the Il23a promoter 13, 14 . Each nucleosome contains the core histones H2A, H2B, H3 and H4, which are characteristically regulated by post-translational modifications, including methylation and demethylation 15 . Published work has indicated Jmjd2d is a demethylase that mediates the demethylation of histone H3 that is involved in the induction of Il12b in DCs 15, 16 . However, how Jmjd2d is regulated has remained unclear.
Here we identified the deubiquitinase (DUB) Trabid ('tumornecrosis factor receptor-associated factor-binding protein domain'; also called 'Zranb1'), as a crucial regulator of TLR-stimulated expression of IL-12 and IL-23. Trabid belongs to the OTU family of DUBs and 'preferentially' hydrolyzes lysine 29 (K29)-and Lys33 (K33)linked ubiquitin chains [17] [18] [19] . In vitro studies of cancer cell lines have suggested a role for Trabid in the regulation of Wnt signaling, but this function remains controversial 20, 21 . By using a gene-targeting approach, we found that Trabid deficiency in DCs and macrophages impaired the induction of Il12 and Il23 without affecting the induction A r t i c l e s of many other cytokine-encoding genes. Consistent with that, Trabid deficiency impaired production of the T H 1 and T H 17 subsets of inflammatory T cells, which rendered mice refractory to the induction of experimental autoimmune encephalomyelitis (EAE), an autoimmune neuroinflammatory disease dependent on T H 1 and T H 17 cells. Our data suggest the involvement of an epigenetic mechanism in which Trabid regulates histone modifications at the Il12 promoter by controlling the fate of the histone demethylase Jmjd2d.
RESULTS

Requirement for Trabid in the induction of EAE
To study the in vivo function of Trabid, we generated mice with germline deletion of the gene encoding Trabid (Zranb1) by crossing mice with loxP-flanked alleles (Zranb1 f/f ) with mice expressing Cre recombinase from the cytomegalovirus promoter ( Supplementary Fig. 1a,b) . In addition, we crossed the Zranb1 f/f mice with mice expressing Cre recombinase from the gene encoding the integrin CD11c (Itgax-Cre; called 'Cd11c-Cre' here) or mice expressing Cre recombinase from the T cell-specific Cd4 promoter (Cd4-Cre) to generate mice with conditional deletion of Zranb1 in DCs (Zranb1 f/f Cd11c-Cre; called 'DC-cKO' here) or mice with conditional deletion of Zranb1 in T cells (Zranb1 f/f Cd4-Cre; called 'T-cKO' here), respectively ( Supplementary Fig. 1c,d) . We crossed heterozygous mice to generate mice with germline or conditional deletion of Zranb1 and their corresponding Zranb1-sufficient (control) littermates. RT-PCR analysis revealed loss of Zranb1 mRNA expression in T cells, B cells, DCs and macrophages of the mice with germline deletion of Zranb1 and in DCs of the DC-cKO mice and T cells of the T-cKO mice (Supplementary Fig. 1e ). The mice with germline deletion of Zranb1 were born at the expected Mendelian ratio and had normal growth and survival (data not shown) and did not show obvious abnormalities in thymocyte development, although they had a moderate reduction in the frequency of naive T cells in the spleen relative to the frequency of these cells in Zranb1-sufficient mice ( Supplementary  Fig. 2a,b) . The frequency of regulatory T cells (T reg cells) among CD4 + single-positive thymocytes and CD4 + splenic T cells was comparable in Zranb1-sufficient mice and mice with germline deletion of Zranb1 (Supplementary Fig. 2c ). Additionally, deletion of Zranb1 had little or no effect on the frequency of conventional DCs or plasmacytoid DCs in the bone marrow and spleen (Supplementary Fig. 2d) .
To investigate the function of Trabid in regulating immune responses, we used the T cell-dependent autoimmunity model EAE, which involves the peripheral generation of central nervous system (CNS)-specific T H 1 and T H 17 subsets of inflammatory T cells and their subsequent migration to the CNS to induce inflammation and demyelination 22, 23 . Zranb1-sufficient mice immunized with a peptide consisting of amino acids 35-55 of myelin oligodendrocyte glycoprotein (MOG(35-55)) along with pertussis toxin developed severe clinical symptoms ( Fig. 1a ) associated with substantial infiltration of cells of the immune system into the CNS and demyelination of the CNS (Fig. 1b) . After immunization with MOG(35-55), mice with germline deletion of Zranb1 displayed significantly delayed onset and reduced severity of EAE disease, as well as substantially less infiltration of cells of the immune system into the CNS and demyelination of the CNS, relative to that of their Zranb1-sufficient counterparts ( Fig. 1a,b) . Flow cytometry revealed fewer CD4 + T cells, CD8 + T cells and CD11b + CD45 hi monocytes, in both frequency and absolute number, along with an increased frequency of CD11b + CD45 lo microglia, in the CNS of mice with germline deletion of Zranb1 than in that of Zranb1-sufficient mice ( Fig. 1c) , during the effector phase of EAE. Consistent with reduced infiltration of inflammatory cells, we detected lower expression of the proinflammatory cytokine-encoding genes Il6, Tnf, Il12a, Il12b and Il23a in the CNS of mice with germline deletion of Zranb1 immunized with MOG than in that of their Zranb1-sufficient counterparts ( Fig. 1d) , which further suggested attenuated induction of inflammation. In addition, the frequency of IL-17 + T H 17 cells and IFN-γ + T H 1 cells among the CD4 + T cells infiltrating the CNS was significantly lower in mice with germline deletion of Zranb1 than in Zranb1-sufficient mice, during the effector phase of EAE induction (Fig. 1e) . Mice with germline deletion of Zranb1 in which EAE was induced also had a significantly lower frequency of T H 1 and T H 17 cells in the draining lymph nodes ( Fig. 1f) and spleen ( Fig. 1g ) than did their Zranb1-sufficient counterparts, as determined by intracellular cytokine staining ( Fig. 1f ) and in vitro recall responses stimulated by MOG(35-55) ( Fig. 1g) . These results suggested impaired generation of inflammatory T cells upon immunization with autoantigen and highlighted a crucial role for Trabid in mediating the in vivo differentiation of T H 1 and T H 17 cells.
Function of Trabid in DCs for regulating T cell differentiation
To determine if Trabid functioned in T cells in a cell-intrinsic manner or regulated the CD4 + T cell responses through an effect on cells of the innate immune system, particularly DCs, we induced EAE in T-cKO and DC-cKO mice. We found comparable EAE disease scores and infiltration of cells of the immune system into the CNS in Zranb1sufficient and T-cKO mice immunized with MOG(35-55) ( Fig. 2a and 
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A r t i c l e s Supplementary Fig. 3a ). In addition, T-cKO mice in which EAE was induced had no defects in the in vivo production of T H 1 and T H 17 cells or in vitro T cell recall responses to MOG relative to that of Zranb1-sufficient mice ( Supplementary Fig. 3b,c) . Consistent with that, the efficiency with which naive CD4 + T cells differentiated in vitro into T H 1, T H 17 and T reg cells was comparable for cells from T-cKO mice and those from Zranb1-sufficient mice ( Supplementary  Fig. 3d ). Zranb1-sufficient and Zranb1-deficient naive T cells also had similar capacity for proliferation and expression of IL-2 and IFN-γ in response to in vitro stimulation via the TCR and the coreceptor CD28 ( Supplementary Fig. 3e,f) . These observations indicated a noncell-autonomous effect of Trabid on the regulation of T cell differentiation and the pathogenesis of EAE. DCs have an important role in regulating the activation and differentiation of naive CD4 + T cells 24 . Similar to mice with germline deletion of Zranb1, DC-cKO mice had delayed onset and reduced severity of EAE disease, as well as a profound reduction in the frequency and absolute number of CNS-infiltrating CD4 + T cells and CD11b + CD45 hi myeloid cells ( Fig. 2b-d ) and a greater frequency of CNS-resident CD11b + CD45 lo microglia ( Fig. 2c) , relative to that of Zranb1-sufficient mice. Intracellular cytokine staining revealed a lower frequency and absolute number of T H 1 and T H 17 cells and a lower number of T reg cells in the CNS of DC-cKO mice than in that of Zranb1-sufficient mice, following the induction of EAE ( Fig. 2e) , which corresponded to the overall reduction in the infiltration of cells of the immune system into the CNS in the immunized DC-cKO mice ( Fig. 2c,d) . We detected a lower frequency of T H 1 and T H 17 cells in the draining lymph nodes of DC-cKO mice than in those of Zranb1-sufficient mice ( Fig. 2e ) and lower T H 1 and T H 17 cytokine recall responses in splenic DC-cKO T cells than in splenic Zranb1sufficient T cells ( Fig. 2f) , which suggested impaired production of these inflammatory T cells. These data suggest that expression of Trabid in DCs regulated the generation of T H 1 and T H 17 cells and the pathogenesis of EAE.
After immunization with MOG(35-55), DC-cKO and Zranb1sufficient mice had a similar frequency of CD11c + CD11b + DCs in the draining lymph nodes that expressed comparable levels of the costimulatory molecules CD80 and CD86 ( Fig. 2g) ; this suggested deletion of Zranb1 did not affect the development, migration or maturation of DCs. However, after immunization with MOG(35-55), DC-cKO mice had reduced expression of the inflammatory cytokineencoding genes Il6, Tnf, Il12a, Il12b and Il23a in the CNS ( Fig. 2h ) and had reduced expression of Il12a, Il12b and Il23a, but not of Il6 or Tnf, in the draining lymph nodes ( Fig. 2h) , relative to that of their Zranb1-sufficient counterparts. Together these observations suggested that Trabid might regulate T H 1 and T H 17 responses through the production of IL-12 and IL-23 in DCs.
Trabid regulates IL-12 and IL-23 expression downstream of TLRs
We next analyzed the effect of Trabid deficiency on TLR-stimulated DC activation and cytokine expression in vitro. Zranb1-sufficient and DC-cKO bone marrow-derived DCs (BMDCs) expressed similar levels of CD80 and CD86 following in vitro stimulation with the TLR4 ligand lipopolysaccharide (LPS) ( Fig. 3a) and displayed a similar ability to mediate antigen-stimulated T cell proliferation, as determined by dilution of the division-tracking dye CFSE in co-cultured OT-II T cells (which have transgenic expressing of an ovalbumin-specific TCR) ( Fig. 3b) . However, culture medium from LPS-stimulated DC-cKO BMDCs induced two-to threefold less differentiation of naive CD4 + T cells into T H 1 and T H 17 cells than did conditioned medium from LPS-stimulated Zranb1-sufficient BMDCs (Fig. 3c) . On the other hand, DC-cKO BMDCs induced T reg cell differentiation similarly to Zranb1-sufficient BMDCs, in either the absence or presence of the exogenous morphogen TGF-β ( Supplementary Fig. 4a ).
Real-time quantitative RT-PCR (qRT-PCR) detected significantly reduced expression of Il12a, Il12b and Il23a mRNA, but similar expression of Ifnb, Il1b, IL6, Tnf, Il10 and Nos2 mRNA, in DC-cKO BMDCs stimulated with LPS ( Fig. 3d) or the TLR3 ligand poly(I:C) ( Fig. 3e ) compared with that of their Zranb1-sufficient counterparts. Similar results were obtained by enzyme-linked immunosorbent assay (ELISA) assessing the amount of secreted cytokines ( Fig. 3f) and by qRT-PCR analysis of BMDCs differentiated with the cytokine Flt3L and stimulated with the TLR9 ligand CpG (Fig. 3g) . The reduced production of IL-12 and IL-23 in LPS-stimulated DC-cKO BMDCs contributed to their defect in promoting T H 1 and T H 17 differentiation, since supernatants of LPS-stimulated DC-cKO BMDCs and Zranb1-sufficient BMDCs stimulated similar levels of T H 1 and T H 17 differentiation in the presence of exogenous IL-12 and IL-23 ( Supplementary Fig. 4b) . We also performed studies with bone marrow-derived macrophages (BMDMs) prepared from mice with conditional deletion of Zranb1 in myeloid cells, generated by crossing of Zranb1 f/f mice with mice expressing Cre recombinase from the myeoid cell-specific Lyz2 promoter (Trabid f/f Lyz2-Cre; called 'M-cKO' here), and mouse embryonic fibroblasts (MEFs) prepared from mice with germline deletion of Zranb1. These BMDMs and MEFs had reduced mRNA expression of Il12 when stimulated with LPS ( Fig. 3h ) or transfected with poly(I:C) (through the use of Lipofectamine) ( Fig. 3i) , respectively, compared with that of their Zranb1-sufficient counterparts. Collectively, these results suggested that Trabid mediated induction of the genes encoding IL-12 and IL-23 and thereby promoted T H 1 and T H 17 differentiation.
Requirement for Trabid in recruitment of c-Rel to the Il12 promoter
To elucidate the molecular mechanism by which Trabid mediated the induction of genes encoding the IL-12 family of cytokines, we investigated the role of Trabid in regulating TLR-mediated activation of mitogen-activated protein kinases (MAPKs), inhibitor of NF-κB (IκB) kinase (IKK) and downstream transcription factors known to regulate the induction of Il12 and Il23 (refs. [25] [26] [27] . DC-cKO BMDCs did not show an appreciable defect in the LPS-stimulated phosphorylation of IKK or its substrates IκBα and p105 ( Fig. 4a ) or in the LPS-stimulated activation of the MAPKs p38, ERK and JNK ( Fig. 4b) , compared with that in Zranb1-sufficient BMDCs. Furthermore, we observed similar levels of nuclear translocation of the NF-κB transcription factors c-Rel, p50, and p65, as well as of transcription factors C/EBPβ and STAT3, in LPS-stimulated DC-cKO and Zranb1-sufficient BMDCs (Fig. 4c) .
Because c-Rel has an important role in the transcription of genes encoding IL-12 cytokines 8, 9, 28 , we used chromatin immunoprecipitation (ChIP) to investigate whether Trabid regulated the TLR-stimulated recruitment of c-Rel to Il12 promoters in DCs. Stimulation of Zranb1-sufficient BMDCs with LPS induced the binding of c-Rel to the promoter of Il12b, particularly between positions −220 and −16, a region known to contain an NF-κB-binding site ( Fig. 4d) , while recruitment of c-Rel to this region was barely detectable in DC-cKO BMDCs (Fig. 4d) . Similar observations were made in BMDCs stimulated with CpG ( Fig. 4d) .
We also assessed the recruitment of c-Rel to several other promoters of cytokine-encoding genes that contain NF-κB-binding sites. LPS substantially induced the binding of c-Rel to the promoters of Il12a and Il12b, but not to that of Ifnb, in Zranb1-sufficient BMDCs, and npg the LPS-stimulated recruitment of c-Rel to the promoters of Il12a and Il12b was significantly reduced in DC-cKO BMDCs relative to that in Zranb1-sufficient BMDCs ( Fig. 4e and Supplementary  Fig. 5a ). We found a low level of LPS-induced binding of c-Rel to the Il1b promoter; however, this occurred in both Zranb1-sufficient BMDCs and DC-cKO BMDCs (Supplementary Fig. 5a ). Another member of the NF-κB family, p50, was recruited to both the Il12 promoters and the Ifnb promoter in LPS-stimulated Zranb1-sufficient BMDCs, and the recruitment of p50 to the Il12 promoters, but not its recruitment to the Ifnb promoter, was attenuated in DC-cKO BMDCs relative to that in Zranb1-sufficient BMDCs (Fig. 4e) . Thus, although Trabid was dispensable for the translocation of NF-κB factors to the nucleus, it was required for the recruitment of c-Rel and p50 to the Il12 promoters.
Regulation of histone modifications at the Il12b promoter by Trabid
When transiently expressed in HEK293 human embryonic kidney cells, Trabid did not physically interact with c-Rel or inhibit the ubiquitination of c-Rel (data not shown), and it did not alter the transcriptional activity of c-Rel in a luciferase reporter assay ( Supplementary Fig. 5b ). We next investigated a possible epigenetic function for Trabid. Gene transcription and gene silencing are associated with active histone modifications, such as trimethylation of histone H3 at Lys4 (H3K4me3), and repressive histone modifications, such as dimethylation of H3 at Lys9 (H3K9me2) and trimethylation of H3 at Lys9 (H3K9me3), respectively [29] [30] [31] . We found that LPS induced H3K4me3, downregulated H3K9me2 and H3K9me3, and did not appreciably alter H3K27me3, in the Il12b promoter of Zranb1-sufficient BMDCs (Fig. 5a) . DC-cKO BMDCs had attenuated induction of H3K4me3 and significantly inhibited removal of the repressive histone marks H3K9me2 and H3K9me3 in both the Il12b promoter ( Fig. 5a ) and the Il12a promoter ( Supplementary Fig. 5c ), compared with such induction and removal at these promoters in Zranb1-sufficient BMDCs. Of note, c-Rel-deficient BMDCs did not show defect in the LPS-induced removal of H3K9me2 and H3K9me3 at the Il12b promoter compared with such removal in Zranb1-sufficient BMDCs (Fig. 5b) , which suggested that these Trabid-dependent epigenetic changes were independent of the recruitment of c-Rel.
To investigate the function of Trabid-mediated histone modifications at Il12 promoters, we assessed the binding of components of the RNA polymerase II (Pol II) preinitiation complex, including Pol II, Pol II phosphorylated at Ser5 and the general transcription factor subunits TFIIB and TFIID, to the Il12 and Il23 promoters. DC-cKO BMDCs had attenuated recruitment of these Pol II complex components to the TATA boxes of the promoters of Il12a, Il12b, and Il23a in response to stimulation with LPS, compared with such recruitment in their Zranb1-sufficient counterparts (Supplementary Fig. 6) . In contrast, Zranb1-sufficient and DC-cKO BMDCs did not show any difference in the LPS-stimulated recruitment of components of the Pol II complex to the promoters of Il1b and Il6 (Supplementary  Fig. 6 ). Collectively, these results suggested a role for Trabid in regulating TLR-induced histone modifications and assembly of the Pol II complex at Il12 promoters.
Requirement for DUB activity for Trabid function
To determine whether the DUB catalytic activity of Trabid was required for the regulation of Il12 promoters, we reconstituted Zranb1deficient MEFs with a retroviral vector encoding wild-type Trabid or a catalytically inactive Trabid mutant (C443A). The C443A Trabid mutant showed nuclear translocation similar to, or even greater than, that of wild-type Trabid (Fig. 5c) . However, wild-type Trabid 'rescued' the poly(I:C)-and Lipofectamine-induced removal of H3K9me2 and H3K9me3 (Fig. 5d) , as well as the recruitment of c-Rel (Fig. 5d) , at the Il12b promoter in Zranb1-deficient MEFs, but the C443A Trabid mutant did not. Consistent with that, reconstitution of Zranb1deficient MEFs with wild-type Trabid substantially promoted poly (I:C)-induced expression of Il12b, Il12a and Il23a mRNA in these cells, but reconstitution with the C443A Trabid mutant did not (Fig. 5e) , and reconstitution with wild-type Trabid had no effect on induction of the control gene Il6 (Fig. 5e) . In similar experiments with BMDCs, reconstitution of DC-cKO BMDCs with wild-type Trabid 'rescued' the induction of Il12a, Il12b, and Il23a, but reconstitution with the C443A Trabid mutant did not ( Fig. 5f,g) . Thus, the DUB catalytic activity of Trabid was essential for its function in the regulation of histone modifications and Il12 induction.
Regulation of the demethylase Jmjd2d by Trabid
We surmised that Trabid might regulate the ubiquitination of a factor involved in regulating histone modification at Il12 promoters. In this context, monoubiquitination of histone H2B at Lys120 is known to promote H3 methylation 32 . However, although LPS upregulated the monoubiquitination of H2B at Lys120 in Zranb1-sufficient BMDCs, a similar level of such monoubiquitination was detected in DC-cKO cells (Fig. 6a) . Because Jmjd2 demethylases have been shown to control the removal of H3K9me2 and H3K9me3 histone marks 33 , we screened all four Jmjd2 proteins by ChIP assay and found that stimulation of Zranb1-sufficient BMDCs with LPS induced the binding of Jmjd2d, but not that of the other members of the Jmjd2 family, to the Il12b promoter ( Fig. 6b and Supplementary Fig. 7a ). Furthermore, LPS-stimulated recruitment of Jmjd2d to the promoters of Il12a and Il12b was largely lost in DC-cKO BMDCs, in contrast to its recruitment in Zranb1-sufficient BMDCs (Fig. 6b,c) . Jmjd2d was associated only weakly with the promoters of Il1b and Il6 in LPSstimulated Zranb1-sufficient BMDCs, and this association was not inhibited in DC-cKO BMDCs (Fig. 6c) . As seen with the inducible removal of H3K9me2 and H3K9me3, the LPS-stimulated recruitment of Jmjd2d to Il12b promoter was not affected by deficiency in c-Rel (Supplementary Fig. 7b) , consistent with the idea that chromatin modifications precede the recruitment of c-Rel. We next investigated the functional contribution of Jmjd2d to the induction of Il12. Incubation of Zranb1-sufficient BMDCs with the selective Jmjd2 inhibitor 5-carboxy-8HQ potently inhibited the LPS-stimulated expression of Il12 and Il23, but not that of Il1b and Il6 (Fig. 6d) . Furthermore, 5-carboxy-8HQ had little or no effect on the induction of Il12 and Il23 in DC-cKO BMDCs (Fig. 6d) , consistent with the impaired recruitment of Jmjd2d to promoters in these mutant cells. Knockdown of Jmjd2d with two different short hairpin RNAs also led to significant inhibition of the induction of Il12 and Il23 in Zranb1-sufficient BMDCs (P = 0.0356 (Il12a), 0.0287 (Il12b) or 0.0489 (Il23a); Supplementary Fig. 7c,d) .
We next investigated the role of Trabid in regulating the ubiquitination and stability of Jmjd2d. The steady-state expression of Jmjd2d in Zranb1-sufficient BMDCs was low, but it was elevated after stimulation with LPS ( Fig. 6e) . However, the amount of Jmjd2d protein was increased only slightly in DC-cKO BMDCs following stimulation with LPS ( Fig. 6e) . This phenotype was not due to altered expression of the gene encoding Jmjd2d, because LPS induced comparable amounts of mRNA encoding Jmjd2d in Zranb1-sufficient BMDCs and DC-cKO BMDCs (Fig. 6f) , which indicated a post-translational mechanism for the regulation of Jmjd2d protein. Indeed, treatment of LPS-stimulated DC-cKO BMDCs with the proteasome inhibitor MG132 restored the amount of Jmjd2d protein to a level similar to that in LPS-stimulated Zranb1-sufficient BMDCs (Fig. 6g) , which suggested that Trabid might stabilize Jmjd2d via deubiquitination. In support of this idea, wild-type Trabid stabilized Jmjd2d in poly (I:C)-and Lipofectamine-stimulated Zranb1-deficient MEFs, but the catalytically inactive C443A Trabid mutant did not (Fig. 6h) . 
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A r t i c l e s Furthermore, both wild-type Trabid and the C443A Trabid mutant physically associated with endogenous Jmjd2d in Zranb1-deficient MEFs reconstituted with wild-type Trabid or C443A Trabid ( Fig. 6i  and Supplementary Fig. 7e) .
To directly investigate the role of Trabid in regulating ubiquitination of Jmjd2d, we analyzed the accumulation of ubiquitinated Jmjd2d in Zranb1-sufficient and DC-cKO BMDCs stimulated with LPS in the presence of the proteasome inhibitor MG132. DC-cKO BMDCs had much more abundant ubiquitination of Jmjd2d than did Zranb1-sufficient BMDCs (Fig. 6j) , which suggested that Trabid negatively regulated the ubiquitination of Jmjd2d. After transfection of vector encoding Trabid (wild-type or mutant) into HEK293 cells, wild-type Trabid inhibited Jmjd2d ubiquitination, but the C443A Trabid mutant did not (Fig. 6k) , and the wild-type Jmjd2d was abundantly conjugated with both Lys11 (K11)-and Lys29 (K29)-linked polyubiquitin chains (Fig. 6l) . Consistent with published in vitro findings showing that 
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Trabid 'preferentially' cleaves K29-linked ubiquitin chains 18, 19 , the wild-type Trabid introduced into cells by transfection (as described above) efficiently reduced the K29 ubiquitination of Jmjd2d (Fig. 6l) , although it also had an inhibitory effect on the K11 ubiquitination of Jmjd2d, albeit a more weak effect than its effect on K29 ubiquitination ( Fig. 6l) . Retroviral transduction of Jmjd2d into DC-cKO BMDCs increased the amount of Jmjd2d protein in these cells (Supplementary Fig. 7f ) and significantly increased the expression of Il12a, Il12b, and Il23a (P = 0.0375 (Il12a), 0.0418 (Il12b) or 0.0282 (Il23a); Supplementary Fig. 7g) . Collectively, these data suggested that in TLR-stimulated DCs, Trabid deubiquitinated and stabilized Jmjd2d and thereby regulated the histone modifications and expression of Il12a, Il12b and Il23a (Supplementary Fig. 8) .
DISCUSSION
The IL-12 family of cytokines has a crucial role in the polarization of CD4 + T cells into T H 1 and T H 17 cells and the pathogenesis of EAE 34 .
In the present study, we identified the DUB Trabid as an essential regulator of Il12 expression in both cells of the innate immune system and fibroblasts. Trabid deficiency impaired the TLR-stimulated expression of Il12 and Il23 in vitro and suppressed T cell polarization and EAE pathogenesis in vivo. Mechanistically, Trabid modulated TLR-induced histone modifications at Il12 promoter regions. Epigenetic factors have a crucial role in the regulation of Il12 (refs. [35] [36] [37] . In particular, the histone demethylases Aof1 and Jmjd2d have been linked to the removal of H3K9me2 and H3K9me3 from the Il12b promoter and thus to promotion of the stimulus-induced recruitment of transcription factors such as c-Rel 16, 38 . Our data suggested a ubiquitin-dependent mechanism for the regulation of Jmjd2d. Along with its inducible synthesis in TLR-stimulated DCs, Jmjd2d underwent ubiquitination and proteolysis, which was counterregulated by the DUB Trabid. Trabid deficiency promoted the degradation of Jmjd2d and inhibited removal of the transcriptionally repressive histone marks H3K9me2 and H3K9me3 at Il12 promoter regions. Deletion of Trabid also inhibited induction of the transcriptionally active histone mark H3K4me3 at Il12 promoter regions. Published studies have shown that methylation of H3K9 and that of H3K4 are mutually regulated, with methylation of H3K9 inhibiting methylation of H3K4 and vice versa 39 . It is thus possible that Trabid might regulate both types of histone-methylation events via the same mechanism, although the possibility that two independent mechanisms are involved cannot be excluded.
Our data suggested that Trabid was dispensable for TLR-stimulated activation of c-Rel but was required for recruitment of c-Rel to Il12 promoters. It is likely that such recruitment of c-Rel might rely on histone modifications, because these epigenetic events were also dependent on Trabid. In further support of that possibility, c-Rel was not required for TLR-stimulated recruitment of Jmjd2d to Il12 promoters or the histone-modification events. We noticed that Trabid regulated di-and tri-methylation of H3K9 in a broad region of the Il12b locus, whereas c-Rel was specifically recruited to the promoter-proximal region of Il12b known to contain a κB enhancer. Thus, although histone modifications might promote the recruitment of c-Rel to Il12 promoters, the specificity with which c-Rel is recruited is probably guided by the κB enhancer. The molecular mechanism underlying the inducible recruitment of Jmjd2d to specific promoters is currently unclear.
A published in vitro study of cancer cell lines has suggested a role for Trabid in regulating transcription mediated by TCF in the Wnt signaling pathway 20 , although this function of Trabid has remained controversial 21 . Trabid has also been shown to interact with and inhibit the K63 ubiquitination of Drosophila TAK1, reducing the expression of downstream genes encoding antimicrobial peptides in flies 40 . TAK1 is a master kinase that mediates activation of IKK and its downstream transcription factor NF-κB, as well as the activation of MAPKs 41 . We found that Trabid was dispensable for TLR-stimulated activation of IKK-NF-κB and MAPKs in mouse DCs. Consistent with that, Trabid deficiency did not affect the induction of various NF-κB target genes, such as Tnfa, Il1b and Il6, but led to specific defect in the induction of Il12. Such distinct activity by Trabid might be due to differences between insect systems and mammalian systems.
The connection between Trabid and Jmjd2d raises the question of whether Trabid regulates additional genes. While this question needs to be addressed in future studies, our current work revealed that Trabid was dispensable for the induction of several other genes, including Ifnb, Tnf, Il1b, Il6, Il10 and Nos2. Our data further suggested an important role for Trabid-mediated induction of Il12 and Il23 in mediating inflammatory T cell responses and the pathogenesis of EAE, an animal model of the autoimmune neuroinflammatory disease multiple sclerosis. These findings indicate that Trabid and Jmjd2d might be potential therapeutic targets for the treatment of inflammatory diseases such as multiple sclerosis.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Mice. Mice in which Zranb1 was targeted (Zranb1 tm1a(EUCOMM)Hmgu ) were generated by the Knockout Mouse Project by targeting of exon 3 of Zranb1 using a FRT-LoxP vector (Supplementary Fig. 1a ). Zranb1 f/f mice (on a C57BL/6 × 129/Sv mixed background) were generated by crossing the mice in which Zranb1 was targeted with FLP deleter mice (Rosa26-FLPe; Jackson Laboratory). The Zranb1 f/f mice were further crossed with CMV-Cre, Cd4-Cre, Cd11c-Cre and Lyz2-Cre mice (all on the C57BL/6 background; all from Jackson Laboratory) to generate mice with germline deletion of Zranb1, T-cKO (Zranb1 f/f Cd4-Cre) mice, DC-cKO (Zranb1 f/f Cd11c-Cre) mice and M-cKO (Trabid f/f Lyz2-Cre) mice, respectively. Heterozygous mice were bred to generate Zranb1-deficient mice (or mice with conditional Zranb1 deficiency) and control Zranb1-sufficient littermates for experiments. Outcomes of animal experiments were collected blindly and recorded based on ear-tag numbers of the experimental mice. Genotyping was performed as indicated in Supplementary Figure 1 . Mice were maintained in specific pathogen-free facility, and all animal experiments were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee of the University of Texas MD Anderson Cancer Center.
Antibodies, plasmids, and reagents. Antibodies used for immunoblot analysis, immunoprecipitation, and ChIP assays are listed in Supplementary Table 1 .
Fluorescence-labeled antibodies are described in the section of flow cytometry and cell sorting. Human Trabid cDNA was amplified by PCR from the pHM6-HA-Trabid plasmid (provided by M. Bienz, Medical Research Council, UK) and inserted into the pCLXSN(GFP) retroviral vector 42 . The HA-tagged catalytically inactive Trabid mutant HA-Trabid C443A,was created by site-directed mutagenesis. Mouse Jmjd2d expression vector (pcDNA-FLAG-mKdm4d) was obtained from Addgene, and the cDNA insert was transferred to the pCLXSN(GFP) vector to generate pCLXSN(GFP)-HA-Jmjd2d. pGIPZ lentiviral vectors encoding a non-silencing control short hairpin RNA and two different Jmjd2d-specific short hairpin RNA were obtained from Thermo Scientific. LPS (derived from Escherichia coli strain 0127:B8) and CpG (2216) were from Sigma-Aldrich. Poly (I:C) was from Amersham, and recombinant mouse cytokine GM-CSF was from Peprotech. The Jmjd2 inhibitor 5-carboxy-8HQ was purchased from Tocris Bioscience.
Induction and assessment of EAE. For active EAE induction, age-and sexmatched mice were immunized subcutaneously with MOG(35-55) (300 µg) mixed in complete Freund's adjuvant (Sigma-Aldrich) containing 5 mg/ml heat-killed Mycobacterium tuberculosis H37Ra (Difco). Pertussis toxin (200 ng; List Biological Laboratories) in PBS was administered intravenously on days 0 and 2. Mice were examined daily and scored for disease severity using a standard scale: 0, no clinical signs; 1, limp tail; 2, paraparesis (weakness, incomplete paralysis of one or two hind limbs); 3, paraplegia (complete paralysis of two hind limbs); 4, paraplegia with forelimb weakness or paralysis; 5, moribund or death. After the onset of EAE, food and water were provided on the cage floor. For visualization of CNS infiltration by cells of the immune system and demyelination, spinal cords of mice in which EAE was induced were collected on day 30 and subjected to staining with hematoxylin and eosin and with Luxol fast blue, respectively. Mononuclear cells were prepared from the CNS (brain and spinal cord) of mice in which EAE was induced, as described 43 , and were analyzed by flow cytometry.
Flow cytometry, cell sorting, and intracellular cytokine staining. Singlecell suspensions of spleen, bone marrow or brains and spinal cords from mice immunized with MOG(35-55) were subjected to flow cytometry using a FACSAria (BD Bioscience) and the following fluorescence-labeled antibodies from eBioscience Pacific Blue-conjugated anti-IFN-γ, anti-CD4, and anti-CD11c; phycoerythrin (PE)-conjugated anti-B220 and anti-IL-17A; allophycocyanin-conjugated anti-CD11b and anti-CD62L; allophycocyaninand indotricarbocyanine (Cy7)-conjugated anti-CD8; and fluorescein isothiocyanate (FITC)-conjugated anti-CD44 and anti-Foxp3.
For intracellular cytokine staining, the CNS-infiltrating T cells were stimulated for 4 h with phorbol 12-myristate 13-acetate plus ionomycin in the presence of monensin and then were subjected to intracellular staining of IFN-γ and IL-17A and flow cytometry.
In vitro CD4 + T cell differentiation. Purified naive CD4 + T cells (CD44 lo CD62L hi ) were activated with plate-bound anti-CD3 and anti-CD28 under T H 0 conditions (5 µg/ml anti-IL-4 and 5 µg/ml anti-IFN-γ), T H 1 conditions (5 µg/ml anti-IL-4 and 10 ng/ml IL-12), T H 17 conditions (5 µg/ml anti-IL-4, 5 µg/ml anti-IFN-γ, 20 ng/ml IL-6, and 2.5 ng/ml TGF-β), or T reg cell conditions (5 µg/ml anti-IL-4, 5 µg/ml anti-IFN-γ, and 1 ng/ml TGF-β) (all antibodies, Supplementary Table 1 ). The concentration of anti-CD3 was 5 µg/ml for T H 0 and T H 1 conditions and 1 µg/ml for T H 17 and T reg cell conditions, whereas the concentration of anti-CD28 was 1 µg/ml for all conditions. After 4 d of activation, T reg cells were quantified by flow cytometry based on staining of Foxp3. For detection of T H 1 and T H 17 cells, the cells were restimulated for 4 h with phorbol 12-myristate 13-acetate and ionomycin in the presence of the protein-transport inhibitor monensin, followed by intracellular staining of IFN-γ and IL-17, respectively.
Generation of BMDCs and BMDMs. Bone marrow cells isolated from
Zranb1-sufficient or DC-cKO mice were cultured for 7 d in RPMI-1640 medium containing 10% FBS supplemented with GM-CSF (10 ng/ml). The differentiated BMDCs were stained with Pacific blue-conjugated anti-CD11c ( Supplementary Table 1 ) and isolated by flow cytometry. In some experiments, BMDCs were also generated using medium supplemented with Flt3L (20 ng/ml). Unless stated otherwise, GM-CSF-differentiated BMDCs were used in the experiments. BMDMs were generated using medium supplemented with the cytokine M-CSF.
For retroviral infection of Zranb1-deficient BMDCs, retrovirus particles were produced by transfection of HEK293 cells (using calcium-phosphate method) with pCLXSN-(GFP)-HA-jmjd2d or pCLXSN-(GFP) control vector, along with the packaging vectors pCL-ampho and VSV-G. BMDCs, differentiated using GM-CSF-supplemented medium for 3 d, were infected with the recombinant retroviruses for 8 h and then underwent continued culture under GM-CSF-supplemented medium. After 5 d, the GFP + cells were sorted by flow cytometry and used for experiments.
Functional assays of DCs in vitro.
The function of DCs was measured based on their ability to mediate antigen-stimulated activation of ovalbumin-specific OT-II cells. DCs isolated from Zranb1-sufficient or DC-cKO mice were incubated for 6 h with 5 mg/ml ovalbumin after stimulated with LPS (100 ng/ml) for 12 h, washed three times with fresh medium, and then mixed with naive OT-II CD4 + T cells (CD44 lo CD62L hi ) labeled with CFSE (carboxyfluorescein diacetate succinimidyl ester). After 3 d, flow cytometry was performed for measurement of the proliferation of OT-II T cells based on CFSE dilution.
For functional examination of DC-secreted cytokines in regulating T cell differentiation, Zranb1-sufficient and DC-cKO DCs were stimulated with LPS for 48 h, and the cell supernatants were collected for inducing T cells differentiation. Naive CD4 + T cells (CD44 lo CD62L hi ) isolated from Zranb1sufficient mice were stimulated for 4 d with plate-bound anti-CD3 (5µg/ml) and anti-CD28 (1 µg/ml) ( Supplementary Table 1 ) plus the DC culture supernatants described above, followed by intracellular cytokine staining and flow cytometry for measurement of the frequency of IFN-γ-producing T H 1 cells and IL-17-producing T H 17 cells or the Foxp3 + T reg cells. In some experiments, exogenous IL-12 and IL-23 were provided. Cytokine induction in DCs was also measured by ELISA and qRT-PCR.
Jmjd2d knockdown. Lentiviral particles were produced by transfection of HEK293 cells (by the calcium-phosphate method) with a pGIPZ lentiviral vector encoding either a non-silencing short hairpin RNA or Jmjd2d-specific short hairpin RNAs, along with the packaging vectors psPAX2 and pMD2. BMDCs, differentiated using GM-CSF-supplemented medium for 5 d, were infected with the lentiviruses for 8 h. After 72 h, the infected cells were enriched by cell sorting by flow cytometry (based on GFP expression) and subsequently used for experiments.
ELISA and qRT-PCR. Supernatants of in vitro cell cultures were analyzed by ELISA using a commercial assay system (eBioScience). For qRT-PCR, total RNA was isolated using TRI reagent (Molecular Research Center) and subjected to cDNA synthesis using RNase H reverse transcriptase (Invitrogen) and oligo(dT) primers. qRT-PCR was performed in triplicate, using the npg iCycler Sequence Detection System (Bio-Rad) and iQTM SYBR Green Supermix (Bio-Rad). The expression of individual genes was calculated by a standard curve method and normalized to the expression of the control gene Actb. The gene-specific PCR primers (all for mouse genes) are in Supplementary Table 2. Immunoblot analysis, immunoprecipitation, and ubiquitination assays. Whole-cell lysates or subcellular extracts were prepared and subjected to immunoblot analysis and immunoprecipitation as described 42 . For ubiquitination assays, cells were pretreated with MG132 for 2 h and then lysed with a Nonidet P-40 lysis buffer (50 mM Tris-HCl, pH7.5, 120 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 1 mM DTT) containing 6 M urea and protease inhibitors. Jmjd2d was isolated by immunoprecipitation with anti-Jmjd2d (93694; Abcam), and ubiquitinated Jmjd2d was detected by immunoblot analysis with anti-ubiquitin (P4D1; Santa Cruz) (antibodies, Supplementary Table 1 ). For transfection models, expression vector encoding FLAG-tagged Jmjd2d was transfected into HEK293 cells along with expression vectors encoding HA-tagged wild-type ubiquitin or mutant ubiquitin, along with other expression vectors, and the transfected cells were pretreated with MG132 for 2 h and then lysed for immunoprecipitation of Jmjd2d, followed by detection of ubiquitinated Jmjd2d by immunoblot analysis with anti-ubiquitin (identified above).
ChIP assays. ChIP assays were performed with DCs (6 × 10 7 ) stimulated for 6 h with LPS or MEFs (2 × 10 7 ) stimulated for 9 h with poly(I:C) plus Lipofectamine. The cells were fixed with 1% formaldehyde and sonicated as previously described 44 . Lysates (from 2 × 10 7 cells in 3 ml) were subjected to immunoprecipitation with the appropriate antibodies ( Supplementary  Table 1 ), and the precipitated DNA was then purified by Qiaquick columns (Qiagen) and quantified by quantitative PCR using a pair of primers that amplify the target region of the indicated promoter (Supplementary Table 3 ). The precipitated DNA is presented as frequency of the total input DNA. For histone-modification analyses, the DNA bound by modified histone H3 is presented as frequency of total histone H3-bound DNA. For all of the genes analyzed, the promoter region covering a well-defined NF-κB-binding site was selected for quantitative PCR assay for analysis of c-Rel recruitment and histone modifications. For analysis of the recruitment of general transcription factor components, the TATA box region of the promoters was selected for ChIP assay and quantitative PCR.
Luciferase reporter gene assays. HEK293 cells (2 × 10 5 ) were transfected, by calcium phosphate precipitation, with a firefly luciferase reporter driven by the Il12b promoter, along with the appropriate cDNA expression vectors, as well as the control pRL-TK promoter-driven renilla luciferase reporter. At 36 h after transfection, cells were collected for dual luciferase assays (Promega). Firefly luciferase activities were normalized by the renilla luciferase activities.
Statistical analysis. Statistical analysis was performed using Prism software. Kruskal-Wallis nonparametric test followed by Dunn's post analysis were performed for analysis of EAE scores, and two-tailed unpaired t-tests were performed for all other data analyses. P values less than 0.05 were considered significant. In the animal studies, four mice were required for each group based on the calculation to achieve a 2.3-fold change (effect size) in a two-tailed t-test with 90% power and a significance level of 5%. All statistical tests were justified as being appropriate, and data met the assumptions of the tests. The variance between the groups being compared statistically was similar. 
